Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rheumatologic Adverse Events and Immunotherapy in Oncology

NCT04791150 is registered in ClinicalTrials.gov with Poitiers University Hospital as lead sponsor.

NCT NCT04791150
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04791150 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rheumatologic Adverse Events and Immunotherapy in Oncology
Lead sponsor
Poitiers University Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
May 7, 2021
Completion date
November 7, 2022
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adverse drug event, arthritis, autoimmunity, oncology